Yamashita Keishi, Mimori Koshi, Inoue Hiroshi, Mori Masaki, Sidransky David
Department of Otoralyngology-Head and Neck Surgery, The Johns Hopkins University, Baltimore, Maryland 21205, USA.
Cancer Res. 2003 Oct 15;63(20):6575-8.
Trypsin is a serine protease family member with a potential role in cancer invasion. We investigated trypsinogen expression at the RNA level in 49 esophageal squamous cell carcinomas (ESCCs) and 72 gastric adenocarcinomas. Almost all primary ESCC tissues (95%) showed reduced expression, and 9 of 13 ESCC cell lines were silenced for trypsinogen expression. Absent expression correlated with promoter hypermethylation of trypsinogen-4 by bisulfite DNA sequence. Moreover, we detected promoter hypermethylation in 50% of primary ESCCs by methylation-specific PCR. A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001). Our results support the notion that trypsin plays a tumor-suppressive role in human carcinoma.
胰蛋白酶是丝氨酸蛋白酶家族成员,在癌症侵袭中可能发挥作用。我们在49例食管鳞状细胞癌(ESCC)和72例胃腺癌中研究了RNA水平的胰蛋白酶原表达。几乎所有原发性ESCC组织(95%)均表现出表达降低,13个ESCC细胞系中有9个胰蛋白酶原表达沉默。通过亚硫酸氢盐DNA测序,无表达与胰蛋白酶原-4启动子高甲基化相关。此外,我们通过甲基化特异性PCR在50%的原发性ESCC中检测到启动子高甲基化。一部分胃腺癌(71%)也表现出胰蛋白酶原降低,同时胰蛋白酶激活的G蛋白PAR2减少,并且有穿透胃壁的倾向(P = 0.001)。我们的结果支持胰蛋白酶在人类癌症中发挥肿瘤抑制作用这一观点。